Stroke Trial, Recruiting NCT05520034 Sponsor: Hiroshima University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05520034
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For stroke patients:

  • People who were sent home from NINSH hospital after a stroke, or who visited NINSH shortly after having a stroke
  • People who are having their first-ever stroke (not a repeat stroke)
  • People who have had any type of stroke, except a specific type called subarachnoid haemorrhage
  • People whose stroke-related disability falls within a certain range on a standard medical scale (modified Rankin Scale score of 0–4, meaning some ability to function independently — confirm with trial site)
  • People aged 18 years or older
  • People of any gender
  • People who are willing to take part and have signed a written consent form

For family caregivers:

  • The main caregiver of an eligible stroke patient, of any gender, aged 18 or older, who lives with the patient and provides their care
  • People who are willing to take part and have signed a written consent form

Who may not be able to join:

For stroke patients:

  • People who have had a stroke before (this would not be their first stroke)
  • People whose stroke was caused by a genetic condition or by a physical injury or accident
  • People with failure of multiple major organs, or who are in the final stage of a terminal illness
  • People who are already taking part in another clinical trial
  • People who do not wish to participate
  • People whose household does not have access to a mobile phone
  • People with a very high level of stroke-related disability on the standard medical scale (modified Rankin Scale score of 5 — confirm with trial site)

For family caregivers:

  • Caregivers who do not live in the same home as the patient
  • People under 18 years of age
  • People who have a diagnosed mental health condition or a diagnosed condition affecting memory and thinking

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: KATM Ehsanul Huq, PhD, Hiroshima University

Phone: +8108057903018

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hiroshima University
Registry
ClinicalTrials.gov
Start date
2 October 2022
Est. completion
28 February 2024

Where this trial is recruiting

Bangladesh

Primary endpoints

Change of the recurrence rate of stroke.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov